Stellaromics Inc. · 20 hours ago
Research Associate
Boston, MA
Full-time
Onsite
Entry, Mid Level
$70K/yr - $95K/yr
1+ years expStellaromics Inc. is an innovative biotech startup founded in 2022, located in Boston, MA, focused on advancing biomedical research through proprietary technology. The Research Associate will support client-facing service operations by delivering high-quality tissue sectioning and processing for 3D spatial transcriptomics assays, ensuring adherence to quality standards and timelines.
3D TechnologyBiotechnology
Responsibilities
Support all service-related spatial transcriptomics workflows (e.g., sectioning, sample preparation, reagent setup, imaging, and data handoff)
Perform consistent, high-quality tissue sectioning using cryostats and microtomes for fresh frozen and FFPE client samples
Process and prepare samples according to validated SOPs for 3D spatial transcriptomics
Participate in continuous improvement of lab workflows and operational efficiency including development of SOPs
Assist with data packaging for customer readouts, reports, and internal reviews
Execute end-to-end service workflows, including sectioning, sample preparation, reagent setup, imaging support, and data/sample handoff according to SOPs and project plans
Ensure accurate sample tracking, labeling, and chain-of-custody throughout all service workflows
Maintain, calibrate, and troubleshoot histology equipment to ensure reliable performance and minimal downtime
Run experiments independently. Document all work, metadata, and deviations in electronic lab notebooks in accordance with quality standards
Collaborate with project managers, scientists, and operations teams to meet client timelines and quality expectations
Adhere strictly to laboratory safety, biospecimen handling, and quality management procedures
Qualification
Required
Bachelor's or Master's degree in biology, molecular biology, biomedical sciences, histotechnology, or a related field; HT/HTL certification a plus
1–3+ years of hands-on histology or tissue processing experience in research, industry, or clinical labs
Demonstrated proficiency in cryosectioning and microtomy of fresh frozen and FFPE tissues
Strong attention to detail and commitment to producing high-quality tissue sections and sequencing data
Ability to follow SOPs, manage multiple tasks, and work both independently and as part of a team
Excellent communication, organization, and data documentation skills
Preferred
Experience with spatial transcriptomics platforms, immunohistochemistry (IHC), IF staining, or image analysis
Experience with RNA-preserving workflows or molecular biology techniques
Prior work supporting customer-facing lab services in regulated lab environments (CLIA, CAP, GLP) is beneficial
Experience with ELNs, LIMS, or sample tracking systems
Benefits
Innovative Technology: Be part of a company at the cutting edge of spatial biology and genomics, revolutionizing the way researchers understand biology.
Impactful Role: You will have a significant impact on the department and the future of the company.
Collaborative Environment: Work with a talented, passionate team in a culture that values creativity, innovation, and teamwork.
Career Growth: As a high-growth company, we offer significant opportunities for professional development and career advancement.
Company
Stellaromics Inc.
Founded in 2022 and headquartered in Boston, Stellaromics is revolutionizing biomedical research with its proprietary technology, unraveling complex 3D transcription and translation patterns within native biological tissue.
11-50 employees
H1B Sponsorship
Stellaromics Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (1)
2024 (1)
Funding
Current Stage
Growth StageTotal Funding
$105MKey Investors
Catalyst4Plaisance Capital Management
2025-02-11Series B· $80M
2023-11-02Series A· $25M
Leadership Team
Ye Fu
Chief Technology Officer and Co-Founder
Recent News
Company data provided by crunchbase